|
MBOAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
3.554100E-02 |
| Normal-vs-Stage3 |
9.04831765069503E-14 |
| Normal-vs-Stage4 |
3.39570038754289E-10 |
| Stage1-vs-Stage2 |
9.222400E-03 |
| Stage1-vs-Stage3 |
3.147800E-01 |
| Stage1-vs-Stage4 |
6.787800E-04 |
| Stage2-vs-Stage3 |
2.735300E-03 |
| Stage2-vs-Stage4 |
4.04940000000575E-05 |
| Stage3-vs-Stage4 |
2.026200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.12439999999603E-05 |
| Normal-vs-Asian |
1.58630000246518E-08 |
| Caucasian-vs-AfricanAmerican |
5.849000E-01 |
| Caucasian-vs-Asian |
1.010420E-01 |
| AfricanAmerican-vs-Asian |
1.726820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35399485962284E-11 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.317970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.09399999947968E-07 |
| Normal-vs-Age(81-100Yrs) |
9.635700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.552000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.101220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.828400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.655440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.858500E-03 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
2.469800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.02859959333546E-11 |
| Tall-VS-Other |
1.157960E-02 |
| Tall-VS-Normal |
6.78620493133053E-11 |
| Follicular-VS-Other |
8.818000E-03 |
| Follicular-VS-Normal |
6.494600E-01 |
| Other-VS-Normal |
7.252100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.99462709974341E-12 |
| Normal-vs-N1 |
5.72509994967163E-09 |
| N0-vs-N1 |
4.519800E-03 |
|
|
